CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
4.180
-0.050 (-1.18%)
Nov 21, 2024, 1:53 PM EST - Market open
CollPlant Biotechnologies Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CLGN stock have an average target of 12.5, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 199.04% from the current stock price of 4.18.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 21, 2024.
Analyst Ratings
The average analyst rating for CLGN stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +163.16% | Aug 21, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +234.93% | Aug 20, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +234.93% | Aug 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +163.16% | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +163.16% | Apr 5, 2024 |
Financial Forecast
Revenue This Year
1.72M
from 10.96M
Decreased by -84.29%
Revenue Next Year
13.26M
from 1.72M
Increased by 670.03%
EPS This Year
-1.28
from -0.62
EPS Next Year
-0.40
from -1.28
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.0M | 15.2M | 22.8M |
| Avg | 1.7M | 13.3M | 20.2M |
| Low | 536,060 | 11.3M | 17.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -72.9% | 784.1% | 71.7% |
| Avg | -84.3% | 670.0% | 52.6% |
| Low | -95.1% | 554.5% | 33.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.12 | -0.19 | 0.02 |
| Avg | -1.28 | -0.40 | -0.03 |
| Low | -1.41 | -0.60 | -0.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.